Preliminary scientific tests suggest conolidine could inhibit specific ion channels, minimizing neuronal excitability and restricting ache alerts. This mechanism is particularly relevant in neuropathic pain, in which abnormal signaling results in persistent discomfort. On top of that, conolidine seems to impact G protein-coupled receptor (GPCR) pathways integral to agony https://josepho566dna1.wikigdia.com/user